<DOC>
	<DOCNO>NCT02943304</DOCNO>
	<brief_summary>This prospective cohort study determine natural history fetal exposure Zika virus ( ZIKV ) effect fetus newborn emphasis neurodevelopment outcome . Exposure fetus determine maternal symptomatology , RT-PCR ZIKV ( blood urine ) serologic test specific ZIKV . Neonates classify accord trimester infection expose unexposed ZIKV .</brief_summary>
	<brief_title>Neurodevelopment Outcome Newborns Exposed Zika Virus ( ZIKV ) Utero</brief_title>
	<detailed_description>Infection Zika Virus ( ZIKV ) emerge disease South America serious public health problem due high prevalence one vector transmit virus , Aedes Aegypti , severe sometimes fatal complication generate fetus woman infect virus pregnancy . Retrospective study show association microcephaly , cerebral calcification , dysgenesis corpus callosum , anomalies central nervous system ( CNS ) . The high risk neurodevelopmental impairment expose newborn major concern . The epidemiologic neurobiological evidence support link infection pregnant woman , trimester infection , development anomaly fetus grow extent Center Disease Control officially make statement support association . Although dimension public health impact still unknown , limited prospective data make counsel pregnant woman difficult , especially consider termination pregnancy . Given evidence support neurotropic quality ZIKV potential variation effect virus may develop fetal brain accord gestational age infection , design prospective cohort study determine whether exposure fetus ZIKV symptomatic mother result fetal CNS anomaly and/or impaired neurodevelopmental outcome newborn . As secondary aim determine effect gestational age severity CNS anomalies neurodevelopmental outcome .</detailed_description>
	<mesh_term>Intellectual Disability</mesh_term>
	<mesh_term>Zika Virus Infection</mesh_term>
	<mesh_term>Microcephaly</mesh_term>
	<criteria>1 . Pregnant woman first prenatal visit ( independent gestational age ) confirm predesigned questionnaire symptom ( ) compatible ZIKV infection ( rash [ exanthema sprout ] , conjunctivitis , arthralgia myalgia , fever ) . Pregnant woman affirmative response categorize two group : Acute Infection : symptom ZIKV infection occur within previous 14 day day pregnant woman attend prenatal visit . Late Infection : symptom ZIKV infection occur 14 day prenatal visit . Gestational age onset symptomatology documented time . 2 . Pregnant woman without symptom ZIKV infection negative RTPCR ZIKV negative specific serologic test ZIKV initial prenatal visit normal prenatal evaluation . These pregnant woman select non highrisk delivery service . 1 . Eligible pregnant woman refuse sign consent participation ZEN Initiative . 2 . Enrolled pregnant woman withdraw consent participate time study .</criteria>
	<gender>Female</gender>
	<minimum_age>13 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Pregnancy</keyword>
	<keyword>Fetal Development</keyword>
	<keyword>Child Development</keyword>
	<keyword>Developmental Disabilities</keyword>
	<keyword>Zika Virus Infection</keyword>
</DOC>